Keymed Biosciences, Inc.'s total assets for Q4 2025 were ¥4.22B, a decrease of -8.89% from the previous quarter. HK:2162 total liabilities were ¥1.44B for the fiscal quarter, a 0.53% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.